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T cells are actively scanning pMHC-presenting cells in lymphoid organs and nonlymphoid tissues (NLTs) with divergent 
topologies and confinement. How the T cell actomyosin cytoskeleton facilitates this task in distinct environments is 
incompletely understood. Here, we show that lack of Myosin IXb (Myo9b), a negative regulator of the small GTPase Rho, 
led to increased Rho-GTP levels and cell surface stiffness in primary T cells. Nonetheless, intravital imaging revealed robust 
motility of Myo9b−/− CD8+ T cells in lymphoid tissue and similar expansion and differentiation during immune responses. In 
contrast, accumulation of Myo9b−/− CD8+ T cells in NLTs was strongly impaired. Specifically, Myo9b was required for T cell 
crossing of basement membranes, such as those which are present between dermis and epidermis. As consequence, Myo9b−/− 
CD8+ T cells showed impaired control of skin infections. In sum, we show that Myo9b is critical for the CD8+ T cell adaptation 
from lymphoid to NLT surveillance and the establishment of protective tissue–resident T cell populations.
The Rho regulator Myosin IXb enables nonlymphoid 
tissue seeding of protective CD8+ T cells
Federica Moalli1, Xenia Ficht1, Philipp Germann2,3,4, Mykhailo Vladymyrov5, Bettina Stolp1, Ingrid de Vries6, Ruth Lyck1, Jasmin Balmer7, 
Amleto Fiocchi8, Mario Kreutzfeldt9, Doron Merkler9, Matteo Iannacone10, Akitaka Ariga5, Michael H. Stoffel7, James Sharpe2,3,4,11, 
Martin Bähler12, Michael Sixt6, Alba Diz‑Muñoz13, and Jens V. Stein1
Introduction
Ag-specific T cells are exceedingly rare at the onset of an adaptive 
immune response (∼1 clone per 105 to 106 T cells) (Tscharke et 
al., 2015). To expedite their encounter with cognate antigen, T 
cells have evolved to dynamically scan the surfaces of peptide–
major histocompatibility complex (pMHC)–presenting cells. 
Studies using two-photon intravital microscopy (2PM) of mouse 
peripheral lymph nodes (PLNs) uncovered that parenchymal 
T cells move in an amoeboid manner on a three-dimensional 
network consisting of fibroblastic reticular cells (FRCs; Bajénoff 
et al., 2006), reaching high migratory speeds (10–15 µm/min). 
This scanning behavior allows them to efficiently interrogate 
dendritic cells (DCs) attached to the FRC scaffold (Katakai et 
al., 2013). Upon encounter of cognate pMHC and costimulatory 
molecules, T cells attach firmly to DCs for several hours and start 
to up-regulate activation markers (Huang et al., 2004; Sumen 
et al., 2004; Cahalan and Parker, 2006). After detachment from 
DCs, activated T cells proliferate before effector daughter cells 
exit via efferent lymphatic vessels or, in spleen, direct release 
into the blood circulation (Schwab and Cyster, 2007).
A key feature of recently activated effector CD8+ T cells is 
their switch from secondary lymphoid organ (SLO) recirculation 
to homing to nonlymphoid tissue (NLT), such as exocrine and 
endocrine glands, mucosal surfaces of the gut and reproductive 
tracts, skin epithelial barriers, or neuronal tissue (von Andrian 
and Mackay, 2000; Nolz, 2015). Compared with the widely 
spaced FRC scaffold of SLOs (Bajénoff et al., 2006; Novkovic et al., 
2016), NLTs display highly divergent properties, including dis-
tinct adhesive or guidance molecules, topologies (e.g., isotropic 
vs. aligned collagen networks), rigidity (e.g., adipose vs. connec-
tive tissue), and confinement (e.g., prevention of cell extensions 
by tissue barriers; Charras and Sahai, 2014). Furthermore, T cell 
accumulation in NLTs requires transmigration in between or 
directly through endothelial cells with organ-specific adherens 
and tight junction protein composition (Furuse, 2009; Dejana 
and Orsenigo, 2013; Tietz and Engelhardt, 2015; Vestweber, 
2015). Afterward, T cells have to breach the extracellular matrix 
(ECM)–rich basement membrane (BM) of endothelial cells, con-
sisting of varying collagen and laminin networks cross-linked by 
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nidogens, perlecan, and other proteins (Kalluri, 2003; Pfeiffer et 
al., 2008; Rowe and Weiss, 2008; Nourshargh et al., 2010; Yousif 
et al., 2013). Finally, in barrier organs (e.g., skin and gut) or secre-
tory glands (e.g., salivary glands), effector CD8+ T cells migrate 
from connective tissue into epithelial layers, which requires 
crossing of the epithelial BM (Breitkreutz et al., 2009; Cauley 
and Lefrançois, 2013; Smith et al., 2015; Thom et al., 2015). In 
skin, this process is facilitated by CXCR3 ligands synthesized by 
keratinocytes (Mackay et al., 2013). After clearance of an infec-
tion, CD62L+CCR7+ central memory T cells (TCM) scan lymphoid 
tissue for fast recall responses, whereas CX3CR1intCD62L−CCR7− 
peripheral memory T cells and CX3CR1highCD62L−CCR7− effector 
memory T cells patrol NLTs and blood, respectively (Sallusto et 
al., 2004; Gerlach et al., 2016). Recent studies have shown that 
many NLTs, including mucosal surfaces, salivary glands, and 
epidermis, are continuously surveilled by CD69+CD103+ tissue–
resident memory CD8+ T cells (TRM) that persist after pathogen 
clearance for prolonged periods of time. In these exposed organs, 
TRM rapidly induce recall responses for tissue-wide protection 
upon reinfection (Ariotti et al., 2014; Iijima and Iwasaki, 2014; 
Schenkel et al., 2014; Stary et al., 2015). Thus, all stages of adap-
tive immune responses require efficient CD8+ T cell motility, 
from the rapid selection of appropriate clones in lymphoid tissue 
to the accumulation of effector T cells (TEFF) at sites of infection 
and the continuous surveillance of SLOs and NLT by memory T 
cell populations.
Migrating leukocytes are characterized by a polarized shape 
with F-actin–rich protrusions at the leading edge and actomyosin 
contractions at the uropod (Krummel and Macara, 2006; Friedl 
and Weigelin, 2008; Paluch et al., 2016). Polarization is stabilized 
by the spatially segregated activation of guanine exchange factors 
(GEFs) and GTPase-activating proteins (GAPs). These enzymes 
control small GTPases of the Rho/Ras family by switching them 
from their inactive GDP-bound state to their active GTP-bound 
state and back (Tybulewicz and Henderson, 2009; Rougerie 
and Delon, 2012; Niggli, 2014). Active Rac-GTP and Cdc42-
GTP at the leading edge of migrating cells enable continuous 
WAVE/Scar-Arp2/3–mediated F-actin polymerization required 
for pseudopod protrusion (Renkawitz et al., 2009; Faroudi et 
al., 2010; Ridley, 2011; Fritz-Laylin et al., 2017). At the trailing 
edge, Rho-GTP signals through a Rho-associated protein kinase 
(ROCK)–Myosin light chain (MLC)–nonmuscle Myosin II 
pathway to promote uropod contractions for detachment from 
adhesive surfaces and for nuclear propulsion (Morin et al., 2008; 
Lämmermann and Sixt, 2009; Jacobelli et al., 2010). In addition, 
F-actin treadmilling and actomyosin contractility of the cell 
cortex determine the general biophysical properties of cells, 
such as cell surface elasticity, cell cortex tension, and in-plane 
membrane tension (Renkawitz and Sixt, 2010; Gauthier et al., 
2012; Diz-Muñoz et al., 2013; Krummel et al., 2014; Bergert et 
al., 2015). Yet, although these properties have been assigned 
to decisive roles during developmental processes and cancer 
metastasis, there is scarce information on how cell surface 
mechanics are regulated in T cells and how they contribute to 
organ-specific adaptive immune responses.
Myosin IXb (Myo9b) is an F-actin–based cytoskeletal motor 
protein with a RhoGAP activity as intramolecular cargo. It 
accumulates at the leading edge of polarized macrophages and 
DCs (van den Boom et al., 2007; Hanley et al., 2010; Xu et al., 
2014). In these cell types, Myo9b deficiency leads to increased 
steady-state Rho-GTP levels and a contracted cell phenotype 
(Hanley et al., 2010; Xu et al., 2014). A role for Myo9b in naive 
and effector/memory CD8+ T cells has not yet been explored. 
Here, we show that CD8+ T cells lacking Myo9b have high steady-
state Rho-GTP levels and a significantly increased resistance to 
elastic deformation that correlated with reduced chemotaxis 
in vitro. Nonetheless, Myo9b−/− CD8+ T cells showed robust 
homing to SLOs and comparable clonal expansion and effector 
differentiation as their WT counterparts during DC- or virus-
triggered immune responses. In contrast, Myo9b−/− effector/
memory CD8+ T cells failed to efficiently seed NLTs. 2PM 
intravital imaging and functional assays revealed that Myo9b is 
required for cells to cross dense ECM barriers such as the BM 
between dermis and epidermis, but less so for motility within 
3D confined environments. Collectively, our data suggest that 
Myo9b-dependent regulation of Rho activity enables CD8+ 
T cells to establish protective effector and memory T cell 
populations in NLTs.
Results
Myo9b regulates Rho-GTP levels and surface stiffness in 
primary T cells
Myo9b is a motorized RhoGAP that negatively controls Rho activ-
ity in myeloid cells (Fig. 1 A; van den Boom et al., 2007; Hanley 
et al., 2010). Microarray data from the ImmGen resource (Heng 
et al., 2008) showed that Myo9b is also constitutively expressed 
in naive and effector/memory T cells (Fig. 1 B), with only a tran-
sient decrease in expression levels early after viral infection. As 
this suggested a function for this protein in adaptive immune 
responses, we examined how lack of Myo9b affects T cell prop-
erties. Primary Myo9b−/− T cells showed a bona fide CD62LhighC-
D44low naive phenotype and expressed CCR7 and LFA-1 at WT T 
cell levels (Fig. S1). In contrast, Myo9b−/− T cells displayed signifi-
cantly increased steady-state Rho-GTP levels (Fig. 1, C and D) and 
augmented levels of the Rho downstream effector pMLC, both 
with and without CCL21 stimulation (Fig. 1 E).
Because Myo9b and small GTPases including Rho act at the 
cell cortex, and cell cortex contractility affects surface elasticity 
(Krieg et al., 2008; Cai et al., 2010), we used atomic force micros-
copy (AFM) to examine the surface mechanics of ConA-stimu-
lated WT and Myo9b−/− CD8+ T cells (Fig. 1 F). In these assays, the 
deflection of the AFM cantilever correlates with the resistance to 
deformation for up to 200 nm below the cell surface. This assay 
therefore measures the mechanical properties of the cell surface 
including the cortical F-actin network. The Young’s modulus of 
elasticity, which is a measure of an object’s resistance to being 
deformed elastically when a force is applied to it, was tightly reg-
ulated around 145 ± 18 Pa (mean ± SEM) in WT T cells. In contrast, 
Myo9b−/− CD8+ T cells showed a significantly increased Young’s 
modulus (191 ± 27 Pa) as compared with WT T cells, with some 
cells showing a Young’s modulus of around 1 kPa (Fig. 1 G). Col-
lectively, Myo9b activity regulates RhoA-GTP levels in primary T 
cells and the mechanical properties of the cell surface.
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Myo9b is required for in vitro polarization and 
migration of T cells
We examined the impact of Myo9b deficiency on T cell behavior 
in vitro. After stimulation with CCL21, Myo9b−/− T cells dis-
played a more rounded phenotype with fewer F-actin ruffles 
as compared with WT T cells (Fig. 1 H), resulting in impaired 
polarization (Fig.  1  I). In line with this finding, Myo9b−/− T 
cells migrated significantly less to the homeostatic chemo- 
kines CXCL12, CCL19, and CCL21 in Transwell assays (Fig. 1 J). 
We obtained similar results when we analyzed migration of 
Myo9b−/− B cells toward homeostatic chemokines, indicating 
that Myo9b facilitates chemotactic responses in all lymphocytes 
(unpublished data). To assess whether increased Rho-GTP lev-
els were directly responsible for the observed migration defect, 
we treated T cells with pharmacological inhibitors of signaling 
pathways downstream of active RhoA (Fig. 1 K). Direct block-
ing of Rho-GTP formation by 1 µM Rhosin (Shang et al., 2012) 
or inhibition of myosin light chain kinase (MLCK), but not 
ROCK or LIM domain kinase 1 (LIMK), rescued the chemotac-
tic response of Myo9b−/− T cells to WT T cell levels (Fig. 1 L). 
We next asked whether absence of Myo9b affected T cell blast 
motility in geometrically more complex 3D collagen matrices, 
a reductionist model for interstitial migration. Myo9b−/− T cell 
speeds were reduced compared with WT T cells (7.2 ± 5.0 µm/
min for WT and 4.3 ± 3.1 µm/min for Myo9b−/− T cells; mean ± 
SD), whereas arrest coefficients (i.e., the percentage of track 
segments slower than 5 µm/min) were increased (Fig.  1, M 
and N). We obtained similar results when we compared WT 
and Myo9b−/− T cell blast migration under agarose, a model for 
2D confined environments (Fig. 1 O). A comparable reduction 
(30–40%) of Myo9b−/− T cells speeds was observed on laminin 
411, 511, or collagen IV–coated slides (unpublished data). In 
contrast, lack of Myo9b had only a minor effect on shear flow 
resistance, as most WT and Myo9b−/− T cells remained attached 
to ICAM-1 + CCL21–coated plates under flow (Fig. 1 P) despite 
reduced crawling speeds for Myo9b−/− T cells (Fig. 1 Q). In sum, 
our analysis suggests that Myo9b is required for optimal in vitro 
motility, whereas integrin-mediated adhesion under flow was 
largely unaffected.
In vivo T cell homing and interstitial motility in SLOs are 
largely preserved in Myo9b−/− T cells
To address the physiological role of Myo9b, we investigated 
the steady-state lymphocyte compartment of Myo9b−/− mice. 
Absence of Myo9b resulted in decreased T cell numbers in the 
thymus, whereas percentages of CD4/CD8 single and double pos-
itive cells and early double negative thymocyte differentiation 
marker expression were comparable to WT counterparts (Fig. S2, 
A and B). Similarly, analysis of bone marrow suspensions revealed 
normal B cell development in the absence of Myo9b (unpublished 
data). The overall compartmentalized architecture of Myo9b−/− 
lymph nodes (LNs) with distinct T and B cell zones was largely 
preserved, although the spacing of the ECM network produced 
by FRCs was more compact, suggesting decreased cellularity. In 
agreement with this, T cell numbers in SLOs were reduced by 
∼50% in Myo9b−/− as compared with WT mice (Fig. S2, C and D). 
As isolated Myo9b−/− lymphocytes did not show increased apop-
tosis compared with WT T cells (unpublished data), we explored 
alternative mechanisms leading to decreased SLO cellularity. To 
examine nonhematopoietic cells as cause for reduced thymic and 
peripheral T cell numbers, we created bone marrow chimera by 
transferring CD45.1+CD45.2+ and CD45.2+ WT or Myo9b−/− bone 
marrow into lethally irradiated CD45.1+ C57BL/6 mice. After 8 wk, 
bone marrow, thymus, spleen, mesenteric LNs (MLNs), and PLNs 
were analyzed by flow cytometry. Whereas normalized WT–WT 
reconstitution ratios were comparable, Myo9b−/− bone marrow 
gave rise to significantly fewer lymphocytes as compared with 
WT bone marrow (Fig. S2, E and F). Collectively, lack of Myo9b 
caused a T cell-intrinsic lymphopenia in thymus and SLOs that 
became aggravated under competitive conditions.
Based on in vitro data and the phenotype of Myo9b−/− mice, 
we hypothesized that Myo9b deficiency translates into defective 
trafficking patterns of naive T cells in vivo. However, adoptive 
transfer experiments into WT hosts uncovered only a minor 
reduction of Myo9b−/− T cells homing to SLOs at 2 h after trans-
fer (Fig. 2 A). To identify the microanatomical location of trans-
ferred T cells, we performed ultrashort homing assays, followed 
by three-dimensional LN reconstructions (Soriano et al., 2011). 
This sensitive assay exposed a minor reduction of Myo9b−/− T cell 
Figure 1. In vitro characterization of primary Myo9b−/− T cells. (A) Outline of nonpolarized versus polarized T cell with small GTPase activity and Myo9b 
distribution, including a scheme of its RhoGAP “cargo.” The red arrow of the polarized cell indicates direction of movement, whereas the green arrow indicates 
uropod contractility. (B) Myo9b gene expression of naive and vesicular stomatitis virus (VSV)-OVA–activated effector and memory T cells isolated from spleen. 
Data are from ImmGen database. (C) Flow cytometry plot of RhoA-GTP levels in resting WT (gray line) and Myo9b−/− T cells (red line). The black line depicts 
background, numbers indicate percentage of positive cells. (D) MFI of RhoA-GTP in WT and Myo9b−/− T cells. Shown is mean ± SEM. Pooled from three mice 
per genotype in one experiment. (E) MFI of pMLC in WT and Myo9b−/− T cells. Pooled from five mice in two independent experiments. (F) Experimental layout 
of AFM-based surface elasticity measurement. The gray and red lines are representative measurements of cantilever deflection after bead contact to WT or 
Myo9b−/− CD8+ T cells. (G) Young’s modulus of elasticity of WT and Myo9b−/− CD8+ T cells. Pooled from two independent experiments. (H) Fluorescent images 
of WT and Myo9b−/− T cells before and after CCL21 stimulation. Arrows indicate F-actin–containing membrane protrusions. Bars, 5 µm. (I) Polarization index of 
WT (gray line) and Myo9b−/− (red line) T cells. Pooled from two independent experiments with a total of 202 WT and 142 Myo9b−/− T cells. (J) Transwell migration 
of WT and Myo9b−/− T cells toward CCL21, CCL19, and CXCL12. Shown is mean ± SEM. Pooled from two to five independent experiments. (K) Scheme of Rho 
signaling pathways and selected inhibitors. (L) Transwell migration of WT and Myo9b−/− T cells to CCL21 in presence of indicated inhibitors. Shown is mean ± 
SEM. Pooled from four independent experiments. (M) Migration speeds of WT and Myo9b−/− T cell blasts in a 3D collagen matrix. (N) Arrest coefficient of WT 
and Myo9b−/− T cell blasts in a 3D collagen matrix. Data in G and H are pooled from four mice per genotype in two independent experiments. (O) Under agarose 
speeds of WT and Myo9b−/− T cell blasts from one experiment. (P) Sustained shear-resistant adhesion of naive WT and Myo9b−/− T cells in flow chamber. Shown 
are percentages of T cells that resisted detachment from ICAM-1 + CCL21 after 10 min of high shear. Pooled from two independent experiments. (Q) Crawling 
speeds of WT and Myo9b−/− T cells on ICAM-1 + CCL21 under physiological shear. Pooled from four independent experiments. Statistical analysis: unpaired 
Student’s t test (D, E, J, M, N, and O); Mann-Whitney test (G, I, and Q); paired t test (P); ANO VA with Sidak’s multiple comparison test against “no inhibitor” (L). 
*, P < 0.05; **, P < 0.01; ***, P < 0.001. Horizontal bars depict mean.
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numbers within the parenchyme as compared with WT T cells, 
while these cells were accumulating in the perivascular space 
(Fig. 2, B and C). Next, we performed intravital 2PM imaging of 
PLNs to assess dynamic motility parameters of Myo9b−/− T cells 
in situ. In contrast to our in vitro migration data, 2PM tracking 
of T cells in popliteal LNs revealed a remarkably robust intersti-
tial motility of Myo9b−/− T cells (Fig. 2 D and Video 1), with only 
minor alterations as compared with WT T cells. Thus, occasional 
Myo9b−/− T cells showed signs of sudden contraction or U-turns 
between periods of normal motility (Video 2). A detailed analy-
sis of intravital image sequences with high temporal resolution 
further revealed that Myo9b−/− T cells were on average more 
rounded, a phenotype that correlated with a minor reduction 
in track speeds and directionality as compared with WT T cells 
(Fig. 2, E–G; and Video 2). Furthermore, Myo9b−/− T cell tracks 
showed a mild increase in arrest coefficients and broader turning 
angles compared with WT T cell tracks (Fig. 2, H and I). Yet, the 
motility coefficient, which is a measure of a cell’s ability to scan 
the environment, remained comparably robust at 40 µm2/min 
for Myo9b−/− T cells (Fig. 2 J). Collectively, Myo9b plays a detect-
able but unexpectedly minor role during naive T cell trafficking 
to and within lymphoid tissue.
Myo9b is dispensable for T cell activation and expansion
Because actomyosin contractility has emerged as a central regu-
lator of immunological synapse (IS) formation with DCs (Comrie 
et al., 2015; Le Floc’h and Huse, 2015; Hashimoto-Tane et al., 2016; 
Thauland et al., 2017), we investigated T cell activation parame-
ters of WT and Myo9b−/− T cells. To address cytoskeletal dynam-
ics, we followed T cell spreading on αCD3-coated plates, followed 
by fixation and F-actin staining at different time points. Myo9b−/− 
T cells showed a delayed but ultimately comparable spread on 
αCD3-coated plates as WT T cells (Fig. S3, A and B). Similarly, 
polyclonal T cell proliferation after αCD3 or αCD3/CD28 mAb 
stimulation was equivalent between both populations (Fig. S3 C). 
To analyze antigen-specific responses, we crossed Myo9b−/− mice 
to OT-I TCR transgenic mice, in which CD8+ T cells recognize the 
OVA257–264 peptide in the context of H2-Kb (Kearney et al., 1994). 
In vitro stimulation with activated DCs pulsed with OVA257–264 led 
to robust proliferation of both WT and Myo9b−/− OT-I T cells over 
a wide range of peptide concentrations (Fig. S3 D).
We examined whether features present in lymphoid tissue, 
such as search and arrest at pMHC-presenting DCs, impact on 
Myo9b−/− CD8+ T cell activation. As a computational framework, 
we modeled in silico encounter frequencies of synthetic WT and 
Myo9b−/− T cell tracks assembled from intravital imaging data 
with abundant (104) and rare (50) DCs distributed in a sphere 
of 1 mm in diameter as surrogate T cell area. In line with the 
modest impact of Myo9b deficiency on the motility coefficient, 
our modeling predicted that Myo9b−/− T cells showed identical 
encounter frequencies at abundant DC levels (99.7% vs. 99.6% WT 
and Myo9b−/− T cells) and only a marginal reduction in encounter 
frequencies under rare DC conditions (20.3% for WT to 15.1% for 
Myo9b−/− T cells; Fig. 3, A and B). To experimentally corroborate 
these data, we transferred 100 nM OVA257–264–pulsed DCs into 
footpads of mice 18 h before transfer of OT-I and Myo9b−/− OT-I 
T cells and performed 2PM imaging and flow cytometry analysis. 
In agreement with our simulations, experimental 2PM imaging 
of reactive LNs showed WT and Myo9b−/− OT-I T cells in close 
apposition to OVA257–264–pulsed DCs (Fig. 3 C and Video 3), with 
Myo9b−/− OT-I cells showing decreased cell speeds and longer DC 
interactions as compared with OT-I T cells (Fig. 3, D and E).
Next, we examined whether CD8+ T cell differentiation was 
affected in the absence of Myo9b. WT and Myo9b−/− OT-I T 
showed a similar expression of the early activation markers CD69 
and CD25 (Fig. 3, F and G; and Fig. S3 E). Despite a minor decrease 
in Myo9b−/− OT-I T cell proliferation at 48 h, OT-I and Myo9b−/− 
OT-I T cells underwent similar cell proliferation at 72  h after 
transfer (Fig. 3, H and I). We obtained comparable data when 
using 1 µM OVA257–264–pulsed DCs (unpublished data). Finally, 
we quantified WT and Myo9b−/− T cell expansion in a microbial 
infection model. OT-I and Myo9b−/− OT-I T cells were transferred 
into GFP+ C57BL/6 recipients, which were subsequently infected 
with an OVA-expressing LCMV strain (LCMV-OVA; Fig. 3 J; Ozga 
et al., 2016). At 6 and 14 d after infection, we observed compara-
ble expansion of both populations in SLOs including spleen, PLN, 
and MLN (Fig. 3 K and Fig. S3 F). Collectively, Myo9b−/− T cells 
interact avidly with DCs and show robust proliferation after in 
vitro and in vivo stimulation, suggesting that T cell activation is 
regulated by Myo9b-independent mechanisms.
Myo9b is required for T cell homing to NLT
We hypothesized that the widely spaced SLO architecture 
(Bajénoff et al., 2006; Novkovic et al., 2016), in combination 
with the permissive transmigration through high endothelial 
venules (HEVs; Mionnet et al., 2011) and the lack of postcapil-
lary venules in spleen, may partially compensate for the lack 
of Myo9b-regulated Rho activity during naive T cell recircula-
tion. In contrast, the switch of effector T cell trafficking to NLT 
may conceivably impose stricter demands on spatiotemporal 
orchestration of the actomyosin cytoskeleton, owing to the 
altered confinement, topology, and barrier structures in these 
organs (Charras and Sahai, 2014). To perform long-term in vivo 
observations, we backcrossed WT and Myo9b−/− OT-I mice to 
fluorescent protein–expressing reporter mice and cotransferred 
GFP+ Myo9b−/− OT-I and dsRed+ OT-I T cells into C57BL/6 mice 
1 d before skin infection with tdTomato- and OVA-expressing 
HSV-1 (HSV-1TOM-OVA; Fig. 4 A). In this model, local HSV-1TOM-OVA 
infection induces the recruitment of effector CD8+ T cells that 
give rise to a TRM population after viral clearance (Ariotti et al., 
2015). As in the LCMV-OVA model, expansion and contraction of 
dsRed+ OT-I and GFP+ Myo9b−/− OT-I T cells after HSV-1TOM-OVA 
were comparable between days 8 to 30 in blood, reflected in simi-
larly sized memory populations in spleen and PLN on day 30 after 
infection (Fig. 4, B and C). In contrast, the recovery of Myo9b−/− 
OT-I TRM cells from skin was significantly reduced as compared 
with WT OT-I T cells (Fig. 4 C). We found a similar reduction of 
Myo9b−/− OT-I T cells in submandibular salivary glands (SMGs), 
an NLT frequently invaded by expanding effector T cells, on day 
30 after HSV-1TOM-OVA infection (Fig. 4 C). A comparable decline 
of recovered Myo9b−/− OT-I T cells was also observed in SMGs on 
day 6 and 14 after systemic LCMV-OVA infection (unpublished 
data). A detailed analysis of HSV-1TOM-OVA–infected skin sections 
revealed strongly reduced numbers of epidermal Myo9b−/− TRM 
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as compared with their WT counterparts, whereas there was no 
significant difference in dermal T cell numbers (Fig. 4, D and 
E). A similar reduction in epidermal Myo9b−/− T cells became 
already detectable during the effector phase (day 8 after infec-
tion), whereas dermal TEFF numbers were slightly increased in 
the absence of Myo9b (Fig. S4). In contrast to the defective NLT 
homing, Myo9b−/− OT-I T cells isolated from tattooed skin and 
LNs on day 30 showed similar expression of CD127 and lack of 
KLRG1 as WT OT-I T cells (Fig. 4 F), and both skin T cell popula-
tions increased CD103, CD69, and CXCR3 expression (Fig. 4 G). 
These data support the notion of a largely intact development of 
adoptively transferred T cells into TCM and TRM cells irrespective 
of Myo9b expression. Collectively, our data indicate that despite 
their equivalent expansion and frequency in SLOs as WT CD8+ T 
Figure 2. Myo9b deficiency causes a mild reduction of in vivo T cell homing and interstitial motility in LNs. (A) Homing ratio of Myo9b−/− to WT T cells 
at 2 h after transfer. Data are pooled from four to six recipient mice of two to three independent experiments. Shown is median with 25 and 75% quartiles and 
minimum/maximum values. (B) 3DIF LN reconstruction of adoptively transferred WT (gray) and Myo9b−/− (red) T cells at 40 min after transfer. HEVs are labeled 
blue. Square length, 35 µm. (C) Localization of adoptively transferred WT (gray) and Myo9b−/− (red) T cells in LNs as percent of recovered cells. Pooled from two 
independent experiments. (D) Top, representative 2PM tracks of migrating WT and Myo9b−/− T cells in LN interstitium. Square length, 15 µm. Bottom, repre-
sentative time-resolved shapes of WT and Myo9b−/− T cells. Bar, 20 µm. (E–J) Quantification of 2PM motility parameters. Pooled from seven image sequences 
in three independent experiments. Circularity analysis (E), mean track speeds (F), meandering index (G), arrest coefficient (H), turning angle distribution (I), 
and motility coefficient analysis (J) of WT and Myo9b−/− T cells in LN interstitium. Horizontal bars in C, F, and G depict mean, whereas horizontal bar in H shows 
median. Statistical analysis: ANO VA with Tukey’s multiple comparison test (A); paired Wilcoxon test (C); Mann-Whitney test (E, G, H, and I); unpaired Student’s 
t test (F). **, P < 0.01; ***, P < 0.001.
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Figure 3. Myo9b is dispensable for T cell activation and expansion. (A) Exemplary synthetic WT (gray) and Myo9b−/− (red) T cell tracks in a 1-mm diameter 
sphere containing 50 DCs (green). (B) Percentage of synthetic WT and Myo9b−/− T cell contacts with at least one DC at high (104) or low (50) DC densities. 100 
synthetic T cell tracks were analyzed over an 8-h period. Shown is median with 25 and 75% quartiles and minimum/maximum values. (C) 2PM image of WT (gray) 
and Myo9b−/− (red) OT-I T cells interacting with 100 nM OVA257–264–pulsed DCs (green). HEVs are depicted blue. Square length, 8 µm. (D and E) Dynamic OT-I T 
cell–DC interaction parameters. Cell speeds (D) and interactions >30 min (E) of WT and Myo9b−/− OT-I T cells with OVA257–264–pulsed DCs. Pooled from four mice 
in two independent experiments. Horizontal bars in D depict mean and horizontal bars in E show median. (F–K) Activation and proliferation analysis of WT and 
Myo9b−/− OT-I T cells. Percent CD69+ (F) and CD25+ (G) WT and Myo9b−/− OT-I T cells at 24 and 48 h, respectively, after T cell transfer into mice containing 100 
nM OVA257–264–pulsed DCs. Shown is mean ± SD. Pooled from three independent experiments with 4–11 mice per condition. (H) Proliferation of e670-loaded 
WT and Myo9b−/− OT-I T cells at 0 (gray shade), 48 (orange), and 72 h (red) after transfer. (I) Quantification of percent divided WT and Myo9b−/− OT-I T cells at 
48 and 72 h after transfer. Shown is mean ± SD. Pooled from three independent experiments with four to seven mice per condition. (J) Experimental layout of 
systemic LCMV-OVA infection. (K) Percentage of Myo9b−/− OT-I T cells normalized to WT OT-I T cells at day 6 and 14 after infection (mean ± SEM). Pooled from 
three independent experiments with six to seven mice per time point. Statistical analysis: unpaired Student’s t test (D and K); Mann-Whitney test (E); ANO VA 
between selected columns with Sidak’s multiple comparison test (F, G, and I). *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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cells, Myo9b−/− T cells are selectively impaired in their accumu-
lation in epithelial barrier tissues.
Myo9b facilitates T cell entry into the epidermal compartment
To examine the impact of Myo9b deficiency on NLT T cell behav-
ior in more detail, we visualized GFP+ Myo9b−/− and dsRed+ OT-I 
TRM cells in epidermis of HSV-1TOM-OVA–infected mice at >30 
d after infection using 2PM. In line with flow cytometry and 
immunohistological data, representative 2PM scans showed 
significantly reduced Myo9b−/− OT-I TRM cell numbers in the 
epidermal layer as compared with OT-I TRM cells (Fig. 5, A–C), 
comparable to the reduction seen with CXCR3−/− OT-I T cells 
(unpublished data; Mackay et al., 2013). We observed similar 
numbers of cotransferred GFP+ versus dsRed+ WT OT-I T cells 
in HSV-1TOM-OVA–infected epidermis, ruling out an influence 
of fluorescent protein expression on T cell accumulation in 
skin (unpublished data). Next, we performed time-lapse 2PM 
image acquisitions in epidermal regions containing relatively 
high Myo9b−/− OT-I T cell numbers to obtain robust datasets of 
dynamic motility parameters. Residual epidermal Myo9b−/− OT-I 
TRM cells showed a more spherical cell shape with fewer protru-
sions as compared with OT-I TRM (Fig. 5, D and E; and Videos 4 
and 5), with some cells spontaneously rounding up as observed 
in LNs (Fig. 5 M). In accordance, mean membrane protrusion 
speeds were decreased in epidermal Myo9b−/− OT-I TRM (Fig. 5 F), 
accompanied by a 30% reduction in cell speeds, as compared with 
WT OT-I TRM (Fig. 5 G). In contrast, epidermal Myo9b−/− OT-I T 
cells showed increased directionality as compared with OT-I T 
cells (Fig. 5 H; and Videos 4 and 5). As a result, in silico generated 
24-h-long synthetic tracks modeled from intravital observations 
predicted a largely preserved ability of Myo9b−/− T cells to scan 
epidermal tissue (Fig. 5 I). In agreement with the modeling, the 
epidermal motility coefficient was comparable between WT and 
Myo9b−/− OT-I TRM (Fig. 5 J). In sum, although Myo9b−/− CD8+ T 
cells were strongly underrepresented in epidermis, Myo9b defi-
ciency had no discernible impact on the tissue scanning ability 
of residual T cells.
Although we focused on epidermal T cell motility param-
eters, our image volumes routinely contained dermal regions 
underlying the epidermal layer, where only few CD8+ T cells 
reside in the memory phase (Gebhardt et al., 2011; Ariotti et al., 
2012). In line with immunohistological data (Fig. 4, F and G), 
2PM reconstructions consistently showed readily detectable 
dermal Myo9b−/− OT-I T cells (Fig. 5 K and Video 6). Although 
dermal Myo9b−/− OT-I T cells showed a slight decrease in cell 
speeds compared with OT-I T cells (Fig.  5  L), both popula-
tions moved considerably faster as compared with epidermal 
T cells, in agreement with previous observations (Gebhardt et 
al., 2011). A detailed analysis of 2PM videos uncovered dermal 
Myo9b−/− OT-I T cells apparently aiming to cross the BM under-
neath the epidermal cell layer, a behavior we rarely observed 
for the few dermal OT-I T cells remaining on day 30 after infec-
tion (Fig. 5, M and N; and Video 7). Thus, 21 of 23 incomplete 
dermal–epidermal translocation events (defined by temporary 
arrest of dermal T cells beneath the TRM-containing epidermal 
layer) were attempted by Myo9b−/− T cells, whereas only two 
were observed for WT T cells.
Myo9b facilitates T cell transmigration through high-
density ECM barriers
Our results suggested that the control of Rho activity by Myo9b 
facilitates the crossing of dense ECM barriers by either allow-
ing protrusion formation at the leading edge and/or lowering 
cell surface stiffness. To directly address this hypothesis, we 
generated in vitro ECM barriers of different densities on top of 
Transwell filter inserts, using either laminin, low density (LD), 
or high-density (HD) collagen preparations. SEM imaging con-
firmed the increased closing of the 5-µm pores in the order of 
laminin < LD collagen < HD collagen (Fig. 6 A). We also tested 
the prototypical BM components laminin 411, laminin 511, and 
collagen IV, but failed to create a homogeneous layer covering 
Transwell pores (unpublished data). We then compared the abil-
ity of WT and Myo9b−/− T cells to accumulate in response to a 
CCL21 gradient across ECM barriers. Migration of WT T cells 
declined with increasing barrier function, but remained clearly 
detectable even in HD collagen–coated wells (Fig. 6 B). In con-
trast, we observed an ascending impact of Myo9b deficiency 
on T cell chemotaxis with increasing barrier density. Although 
uncoated or laminin-coated filters confirmed the base-line 
reduction of Myo9b−/− T cell chemotaxis, LD, and, in particular, 
HD collagen–coating precipitated a marked decrease in the num-
bers of transmigrated Myo9b−/− T cells (Fig. 6, B and C). Com-
pared with uncoated wells, Myo9−/− T cells showed a further 52 
and 81% reduction in transmigration through LD and HD collagen 
barriers, respectively. We obtained similar results when we ana-
lyzed Myo9b−/− T cell transmigration through the ECM matrix 
deposited by two epithelial cell lines (Fig. S5). Transmigration of 
Myo9b−/− T cells through HD collagen–coated Transwell inserts 
was reestablished by pharmacological inhibition of active Rho 
and MLCK, but not ROCK and LIMK (Fig. 6 D). Collectively, our in 
vitro transmigration results uncover a prominent role for Myo9b 
to allow crossing of dense ECM barriers, resembling the impaired 
epidermal accumulation of Myo9b−/− T cells in vivo.
Myo9 is required for efficient early control of 
viral spread in skin
We analyzed whether the reduced efficacy of NLT seeding of 
Myo9b−/− T cells impaired protection in a local skin infection 
model. To this end, we examined whether recruitment of TCM 
cells, which efficiently home to inflamed skin (Osborn et al., 
2017), is impaired in the absence of Myo9b. We transferred WT 
or Myo9b−/− OT-I TCM cells into perforin-deficient (Prf-1−/−) hosts 
that are unable to efficiently kill virus-infected cells. 1 d later, 
we challenged Prf-1−/− mice with a local skin infection of HSV-
1TOM-OVA and measured viral titers at 60 h after infection (Fig. 7 A; 
Ozga et al., 2016). WT but not Myo9b−/− OT-I cells significantly 
decreased viral titers at this time point as compared with Prf-
1−/− mice that had not received T cells, suggesting that trafficking 
to skin early after viral infection is impaired in the absence of 
Myo9b activity (Fig. 7 B).
Myo9 is required for TRM-mediated global skin immunity
Finally, we investigated how Myo9b affects the function of estab-
lished TRM populations. In a first set of experiments, we analyzed 
the TCR responsiveness of epidermal WT and Myo9b−/− OT-I T 
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cells created after HSV-1TOM-OVA skin infections. To this end, we 
administered OVA257–264 peptide in situ and followed T cell shape 
changes by 2PM as surrogate readout for TCR signaling (Ariotti 
et al., 2012). Epidermal Myo9b−/− OT-I TRM cells displayed a simi-
lar rounding and motility arrest as WT OT-I T cells after peptide 
stimulation (Fig. 8, A–C). Furthermore, WT and Myo9b−/− OT-I 
Figure 4. Myo9b is required for T cell accumulation in NLTs. (A) Experimental layout of HSV-1TOM-OVA skin infection. (B) Percentage of WT and Myo9b−/− OT-I 
T cells in blood on days 8, 14, and 30 after infection. (C) Percentage of WT and OT-I Myo9b−/− T cells (FSC/SSC/singlet gate) in spleen, PLN, MLN, SMG, and skin 
of HSV-1TOM-OVA–infected mice on day 30 after infection. Each dot represents data from one mouse in two independent experiments. (D) WT and Myo9b−/− OT-I 
T cells (brown) in epidermis (blue circles) and dermis (yellow circles) on day 30 after infection IHCS were counterstained with Mayer’s Hematoxylin. Nuclei 
are in blue. Bars, 50 µm. (E) Quantification of WT and Myo9b−/− OT-I T cell distribution per cm2 of epidermis (Epi) or dermis (D). Each dot represents one skin 
section pooled from two independent experiments with three mice and six sections analyzed per genotype. (F) Flow cytometry of activation parameters of WT 
and Myo9b−/− OT-I T cells on day 30 after infection in PLN and skin. Filled-color histograms are isotype controls. (G) Flow cytometry of activation parameters 
of WT and Myo9b−/− OT-I T cells on day 30 after infection in skin. Filled-color histograms are FMO controls. Statistical analysis: unpaired Student’s t test (B and 
C); ANO VA between selected columns with Sidak’s multiple comparison test. ***, P < 0.001. Horizontal bars depict mean. 
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Figure 5. Myo9b is required for dermal T cell entry into epidermis. (A) 2PM image of dsRed+ OT-I and GFP+ Myo9b−/− OT-I T cells in skin on day 30 after 
HSV-1TOM-OVA infection. The right panel identifies individual OT-I (white circles) and Myo9b−/− (red circles) OT-I T cells. (B) Percentage of WT and Myo9b−/− OT-I T 
cells per field of view. (C) Ratio of WT and Myo9b−/− OT-I T cells in epidermal layer. Each dot represents one field of view collected from six mice in two indepen-
dent experiments. Dotted line represents equal number of OT-I versus Myo9b-deficient OT-I T cells in a field of view. (D) 2PM image of OT-I and Myo9b−/− OT-I 
T cell. (E–H) Dynamic motility parameters in epidermis. Sphericity (E), mean protrusion speed (F), single cell speeds (G), and turning angles (H) of epidermal 
OT-I and Myo9b−/− OT-I T cells. (I) Exemplary synthetic WT (gray) and Myo9b−/− (red) T cell tracks derived from 2PM datasets and projected over a 24-h period. 
(J) Motility coefficient of epidermal OT-I and Myo9b−/− OT-I T cells. (K–N) Dynamic motility parameters in dermis. (K) 2PM image of dermal T cells (>25 µm 
below the epidermal TRM layer). Arrowheads depict Myo9b−/− OT-I T cells. (L) Single cell speeds of dermal OT-I and Myo9b−/− OT-I T cells. (M) 2PM image of 
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TRM cells sorted from skins of HSV-1TOM-OVA–infected mice showed 
comparable in vitro cytotoxicity against OVA257–264–pulsed target 
cells (Fig. 8 D), suggesting equivalent TCR activation and cyto-
toxic capacity. To assess the protective function of TRM popula-
tions in the absence of Myo9b, we generated skin-resident OT-I 
T cells phase by tattooing OVA257–264 peptide onto the skin of 
Prf1−/− mice at day 3 after infection with LCMV-OVA (Fig. 8 E). 
Tattoo-induced skin inflammation led to TEFF recruitment and 
local cognate antigen increases TRM generation (Mackay et al., 
2012; Khan et al., 2016). On day 30 after infection with LCMV-
OVA, we challenged sensitized as well as contralateral skin 
sections with HSV-1TOM-OVA in presence of the S1P1 antagonist 
FTY720 to prevent recruitment of circulating effector/memory 
T cells (Pan et al., 2017). At 60 h after infection with HSV-1TOM-OVA, 
we determined viral titers in sensitized and contralateral skin. 
OVA257–264–sensitized skin of WT OT-I T cell recipients showed 
significantly lower viral titers as compared with untreated Prf1−/− 
mice that served as control for maximal viral titers. Of note, the 
contralateral skin of mice that had received WT OT-I T cells 
also showed decreased viral titers, in line with a global immu-
nity provided by skin-resident TRM (Fig. 8 F; Jiang et al., 2012). 
In OVA257–264–sensitized skin of Myo9b−/− OT-I T cell recipients, 
we observed a comparable reduction in HSV-1TOM-OVA titers as in 
sensitized skin of WT OT-I recipients. This result suggests that 
despite reduced skin homing, cognate peptide tattooing resulted 
in sufficient recruitment and expansion of Myo9b−/− CD8+ T cells 
to form a residual TRM population. In contrast, Myo9b−/− T cells 
failed to provide global skin immunity because the contralateral 
side showed no decrease of HSV-1TOM-OVA titers as compared with 
nonimmunized Prf1−/− mice (Fig. 8 F). Thus, our data support a 
pivotal role for Myo9b to endow effector T cells the ability to 
enter and persist in NLTs for global host protection, in addition 
to impaired early antiviral responses (Fig. 7).
Discussion
Activation of CD8+ T cells triggers their switch from a SLO- to an 
NLT-trafficking pattern. In NLTs, effector T cells eliminate viral 
reservoirs and establish protective memory T cell populations. 
Numerous studies have identified adhesion molecules, chemo-
kine receptors, and tissue-specific cues allowing effector T cell 
recruitment and TRM development (von Andrian and Mackay, 
2000; Schenkel and Masopust, 2014; Nolz, 2015; Mueller and 
Mackay, 2016). In contrast, it remains poorly understood how 
dynamic regulation of the actomyosin cytoskeleton supports the 
remarkable adaptation of effector T cells to NLT microenviron-
ments. Our data show that, despite minor defects in SLO traffick-
ing patterns, Myo9b−/− CD8+ T cells retained central features of T 
cells, such as encounter and interaction with cognate pMHC-pre-
senting DCs and expansion after stimulation. In contrast, lack of 
Myo9b led to a striking inhibition of CD8+ T cell accumulation in 
NLTs that strongly correlated with defects in BM barrier–cross-
ing capacity. One conceivable explanation for this phenotype is 
that reduced protrusion formation, correlating with increased 
cell surface stiffness, impairs Myo9b−/− T cell seeding of NLTs 
during the effector phase, whereas SLOs with permissive HEVs 
and widely spaced fibroblast networks are successfully surveilled 
by these cells. These data also support the notion of significant 
differences in the physical constraints imposed on motile T cells 
in lymphoid versus nonlymphoid tissues, although this needs to 
be further explored in future experiments.
>70 GEFs and 60 GAPs regulate small GTPase activity, and 
many of them are expressed in leukocytes (Tybulewicz and 
Henderson, 2009). Yet, there is scarce information on how reg-
ulation of small GTPase activity through GEFs and GAPs impacts 
on the distinct stages of T cell responses in SLOs and NLTs. The 
high expression levels of Myo9b in naive and effector/memory 
CD8+ T cells prompted us to use AFM to examine its impact on cell 
surface mechanics in the absence of chemotactic stimulation. The 
median value of the Young’s modulus of 0.15 kPa allocates CD8+ T 
cells to the lower end of the cell stiffness scale, which ranges from 
∼0.1 kPa to >10 kPa in fibroblasts (Alonso and Goldmann, 2003). 
Similar values were previously reported for human T cells using 
micropipette-aided microindentation or stepwise compression 
between two parallel plates, suggesting that lymphocytes regu-
late the mechanical properties of their cell surface within a nar-
row range (Bufi et al., 2015; Guillou et al., 2016). In the absence 
of chemokine stimulation, Myo9b−/− CD8+ T cells showed a 30% 
increase in the median Young’s modulus, presumably owing to 
augmented cell cortex contraction by actomyosin filaments. 
Although this increase is small as compared with differences in 
Young’s modulus between distinct cell types, in vitro migration 
data support a close correlation of increased cell surface stiffness 
with impaired motility. This was unexpected, because increased 
Rho-ROCK–Myosin II–mediated contractility induces polarity 
and spontaneous motility in neutrophils and other cell types, 
therefore playing a pro- rather than antimigratory role (Niggli, 
2003; Xu et al., 2005; Ruprecht et al., 2015; Vargas et al., 2016). A 
likely explanation for this discrepancy is the directed activity of 
Myo9b at the leading edge for local suppression of Rho activity 
(Hanley et al., 2010), thereby facilitating protrusion formation 
by Rac and Cdc42. Thus, although Rho-mediated contractility at 
the uropod is central to leukocyte motility in 3D environments, 
our data suggest that its activity at the leading edge must be con-
tained for optimal migration. After CCL21 stimulation, pMLC 
levels were further increased in Myo9b−/− T cells and the cells 
were less polarized than their WT counterparts. This indicates 
that Myo9b regulates both basal and chemokine receptor-trig-
gered Rho-GTP levels that control cell surface elasticity and 
protrusive activity. Inhibition of Rho-GTP rapidly reversed the 
failed translocation event of a dermal Myo9b−/− OT-I T cell (arrowhead). The red-circled cell represents a spontaneously rounding epidermal Myo9b−/− OT-I T 
cell. Time in min and s. (N) Quantification of attempted epidermal translocation events of dermal WT and Myo9b−/− OT-I T cells compiled from eight image 
sequences in three independent experiments. Mean protrusion rates at the cell periphery were collected from three image sequence movies of two different 
experiments. Statistical analysis: (B) paired Student’s t test; (F, G, and L) unpaired Student’s t test; (E and H) Mann-Whitney test. *, P < 0.05; **, P < 0.01; ***, 
P < 0.001. Horizontal bars depict mean. Bars: 30 µm (A); 10 µm (D); 40 µm (K); 20 µm (M).
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migration defect in Myo9b-deficient T cells. Similarly, MLCK 
inhibition reestablished the chemotactic response of Myo9b−/− T 
cells, in agreement with its accumulation at the leading edge of 
polarized T cells (Smith et al., 2003). In addition to regulating 
cell spreading, increased RhoA activity impairs vesicle transport 
to the cell surface of activated T cells by strengthening cortical 
actin networks (Johnson et al., 2012), thereby potentially inhib-
iting secretion of ECM-degrading enzymes (Prakash et al., 2014). 
Although this does not account for the basal defect in directed 
motility of naive Myo9b−/− T cells across uncoated or ECM-coated 
Transwell filters, we cannot exclude a role for this process in 
defective TEFF accumulation in the epidermis. Yet, the observa-
tion that Granzyme B–dependent cytotoxicity of Myo9b−/− TRM 
was comparable to WT T cells suggests that vesicle fusion was 
not strongly impaired in the absence of Myo9b. Furthermore, 
WT and Myo9b−/− TEFF showed similar surface levels of LAMP-1, 
a marker for degranulation on lymphocytes, after in vitro activa-
tion (unpublished data).
Naive Myo9b−/− T cells retained robust motility in lymphoid 
tissue that is made up of a widely spaced FRC scaffold filled with 
DCs, lymphocytes, and other cells. Thus, the lymphoid microen-
vironment ameliorated the migratory defect observed in vitro. 
Figure 6. Myo9b facilitates T cell transmigration through increasingly tight ECM barriers. (A) Scanning electron micrographs of uncoated, laminin, LD, 
and HD collagen–coated Transwell filters with 5-µm pore size. Bars: 20 µm (top row); 5 µm (bottom row). (B) Chemotactic migration as percent of input of 
WT and Myo9b−/− T cells in uncoated and coated Transwell filters. Pooled from three independent experiments. Horizontal bars depict mean. (C) Normalized 
ratio of WT and Myo9b−/− T cell migration through uncoated and coated Transwell filters. Shown is mean ± SEM. (D) Chemotactic migration as percentage of 
input through HD collagen–coated Transwell filters in presence of indicated inhibitors. Pooled from three independent experiments. Shown is mean ± SEM. 
Statistical analysis: unpaired Student’s t test (B); ANO VA against “uncoated” and “untreated”, respectively, with Dunnett’s multiple comparison test (C and D). 
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
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In line with this, recent reports showed that a mild degree of 
confinement has a promigratory impact on in vitro cell motility 
through frictional force transmission of the actomyosin cortex 
to substrates with low adhesiveness (Liu et al., 2015; Ruprecht et 
al., 2015). Although ICAM-1 is highly expressed in the lymphoid 
microenvironment, lack of LFA-1–ICAM-1 interactions has only 
a minor effect on T cell motility parameters in vivo (Woolf et al., 
2007; Boscacci et al., 2010), indicating that T cell adhesiveness 
in SLOs is likely to be low in the absence of TCR signaling and 
shearing. Consistent with the largely preserved Myo9b−/− T cell 
motility in lymphoid tissue, Myo9b deficiency did not preclude T 
cell–DC encounters, but rather stabilized their interactions. This 
may be a result of the decreased responsiveness of Myo9b−/− T 
cells to promigratory chemokines such as CCL21, which have 
been reported to exert a disruptive effect on T cell attachment to 
DCs (Dustin, 2004). During interactions with DCs, IS formation 
in T cells is characterized by centripetal F-actin flow important 
for the proper localization of TCR microclusters (Dustin and 
Depoil, 2011). Recent studies have uncovered that Rho-triggered 
actin filament nucleation by formins plays an important role in 
this process (Murugesan et al., 2016; Hui and Upadhyaya, 2017). 
Furthermore, changes in cytoskeletal rigidity affect IS size and 
early TCR signaling in CD4+ T cells (Thauland et al., 2017). None-
theless, in the experimental settings used here, Myo9b−/− CD8+ T 
cells showed comparable activation marker up-regulation, pro-
liferation, acquisition of cytotoxic effector functions, and TCM 
differentiation as WT CD8+ T cells. This suggests that additional 
factors regulate Rho activity at the IS interface, such as Fam65b 
(Froehlich et al., 2016).
In contrast to the preserved scanning and effector 
differentiation, we observed a striking defect of Myo9b−/− 
CD8+ T cell accumulation in NLTs. NLTs are typically composed 
of a “functional” parenchymal compartment, consisting of 
epithelial structures, such as secretory acini of salivary glands 
or the epidermal layer in skin, and “supportive” interstitial 
compartments, containing connective tissue, blood and lymph 
vessels, and innervation. We detected similar numbers of 
dermal Myo9b−/− T cells as compared with WT T cells during the 
effector and memory phase, suggesting that the BM surrounding 
postcapillary venules in nonimmunoprivileged tissues only 
causes a minor delay in Myo9b−/− T cell recruitment. In line with 
this, imaging studies of inflamed endothelial BM have identified 
regions of relatively low ECM deposition as preferential exit 
points for transmigrating leukocytes (Wang et al., 2006). Such 
permissive structures may mitigate the barrier-crossing defects 
of Myo9b−/− T cells. In contrast, epidermal T cell accumulation 
was perturbed in the absence of Myo9b. Interstitial and 
parenchymal compartments are separated by tissue-specific, 
50- to 300-nm thick BMs that serve as structural scaffold for 
endothelial and epithelial layers and consist of self-assembling 
collagen IV and laminin networks cross-linked by nidogens 
and perlecan (Rowe and Weiss, 2008; Sorokin, 2010). During 
normal tissue surveillance, billions of leukocytes traverse BMs 
each day without apparent proteolytic degradation, suggesting 
the involvement of an actomyosin-driven force generating 
mechanism (Huber and Weiss, 1989; Rowe and Weiss, 2008; 
Sorokin, 2010). Yet, the requirements imposed on the actomyosin 
cytoskeleton for successful transition of BM barriers versus 
navigation through interstitial and parenchymal compartments 
have not been comprehensively examined under physiological 
conditions. Our data suggest that control of cell surface elasticity 
and concomitant protrusion formation by Myo9b is most critical 
when T cells traverse BM barriers separating spatially confined 
tissue compartments. We hypothesize that this is a result of the 
requirement to protrude thin filopodia or pseudopods through 
gaps in the BM matrix to clear a path for the larger organelles 
of the cell, in particular the nucleus (Nourshargh et al., 2010; 
Wolf et al., 2013; Paluch et al., 2016). Our controlled in vitro 
transmigration experiments indicate that T cell crossing of 
BM-like structures requires Myo9b-mediated suppression of 
Rho activity, with an inverse correlation to the density of the 
ECM barrier. In contrast, although T cell motility and shape 
parameters depend on whether cells migrate in connective 
or epithelial tissues, T cell motility within a cell matrix is 
less dependent on localized suppression of Rho function by 
Myo9b. Conceivably, T cells migrating within a cell matrix may 
Figure 7. Myo9b is required for early protection in a local skin infection model. (A) Experimental setup of local HSV-1TOM-OVA infection model with OT-I 
and Myo9b−/− OT-I TCM transfer (5 × 105/mouse) in Prf1−/− mice. (B) Viral skin titers at 60 h after infection after transfer of no cells, WT, or Myo9b−/− OT-I TCM. 
Each dot represents skin viral titers from one mouse. Bar depicts median. Data were pooled from two experiments and analyzed using a Kruskal Wallis test 
against “no cells” with Dunn’s multiple comparison test. ***, P < 0.001. Horizontal bars depict mean.
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experience comparable resistance from all directions, whereas 
BM may constitute a high resistance barrier. According to 
this model, interstitially migrating T cells generally choose 
the path of “least tissue resistance” through formation of new 
F-actin protrusions away from obstacles such as BM detected by 
Myo1g and other sensors (Gérard et al., 2014). As consequence, 
crossing of ECM barriers requires actin polymerization–driven 
transformation of chemoattractant gradients into mechanical 
work, thus overcoming the intrinsic propensity of T cells to 
choose the path of least tissue resistance. A prime example is 
the requirement of CXCR3 ligand expression by keratinocytes 
for efficient epidermal seeding of CD8+ T cells (Mackay et al., 
2013). Consistent with the barrier function of BM, stromal ECM 
structures have been shown to reduce T cell infiltration into 
human tumors (Salmon et al., 2012). This raises the interesting 
option to modulate T cell infiltration capacity for adoptive cell 
transfer therapies in cancer immunotherapy, e.g., by increasing 
their likelihood to cross stromal barriers through actomyosin 
adaptation. In this context, modulation of Rho signaling 
pathways in cytotoxic T cells has been recently associated with 
Figure 8. Myo9 enables T cell-mediated global skin immunity. (A) 2PM images of WT (closed arrowheads) and Myo9b−/− (open arrowheads) OT-I TRM at 
indicated time after OVA257–264 peptide tattooing. Bars, 20 µm. (B and C) Quantification of 2PM data pooled from six image sequences in two mice from one 
experiment. WT and Myo9b−/− OT-I TRM speeds (B) and sphericity (C) at indicated time after OVA257–264 peptide tattooing. (D) In vitro killing efficacy of sorted 
WT and Myo9b−/− OT-I TRM. Pooled from two independent experiments. (E) Experimental strategy to generate WT and Myo9b−/− T cells in skins of Prf1−/− mice, 
followed by HSV-1TOM-OVA challenge. (F) Viral titers at 60 h after infection with HSV-1TOM-OVA after transfer of WT or Myo9b−/− OT-I T cells in OVA257–263–tattooed 
and untreated contralateral skin flank. Each dot represents skin viral titers from one mouse. Pooled from two experiments. The dotted line corresponds to viral 
titers after “no cell” transfer (i.e., untreated Prf1−/− mice). Statistical analysis: ANO VA with Tukey’s multiple comparison test (B and C); ANO VA (D); Kruskal Wallis 
test against “no cells” with Dunn’s multiple comparison test (F). *, P < 0.05; **, P < 0.01; ***, P < 0.001. Horizontal bars depict mean.
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improved tumor eradication, although it remains an open issue 
whether this correlated with improved CD8+ T cell infiltration 
into tumors (Zhou et al., 2014). Additional experiments are 
needed to gain a more comprehensive picture of the precise 
constraints exerted by ECM barriers at distinct tissue sites, 
e.g., by measuring their physical properties and recreating key 
features in reductionist in vitro models.
TRM play an important role for host defense by seeding NLTs 
exposed to microbes, such as lung, gastrointestinal tracts, skin, 
and the mucosal surfaces of the reproductive track (Shin and 
Iwasaki, 2012; Schenkel and Masopust, 2014; Iijima and Iwasaki, 
2015; Mueller and Mackay, 2016). Upon exposure to cognate 
peptide, TRM generated in previous infections induce a state of 
tissue-wide alert, effectively blocking viral or bacterial replication 
(Ariotti et al., 2014; Schenkel et al., 2014; Steinbach et al., 2016). 
Our data show that in addition to sensitized areas, remote skin 
areas are also seeded by WT T cells, albeit likely in much lower 
numbers (Gebhardt and Mackay, 2012), to provide global skin 
immunity (Jiang et al., 2012). Although T cell differentiation and 
cytotoxic activity were not impaired in the absence of Myo9b, 
Myo9b−/− CD8 T cells failed to seed epithelial barrier tissues in 
large numbers. Nonetheless, in acutely inflamed skin and in 
the presence of cognate antigen, sufficient Myo9b−/− TEFF cells 
expanded and differentiated to TRM to provide protection against 
a local viral reinfection. In contrast, our data suggest that homing 
of Myo9b−/− TEFF to nonsensitized skin was too low to yield a 
protective TRM population. Collectively, our observations support 
a scenario where, in case of strong inflammation (caused here 
by systemic LCMV infection combined with skin tattooing), 
proinflammatory signals in serum such as TNF-α or IL-1 trigger 
a general increase in endothelial cell adhesiveness that allow 
WT TEFF to disseminate into numerous NLTs for systemic TRM 
generation (Kadoki et al., 2017). TRM accumulation is most 
effective in acutely inflamed tissue (e.g., tattooed skin) and 
when local antigen boosts their numbers (Khan et al., 2016). The 
tissue protection afforded by Myo9b−/− TRM in sensitized skin 
areas suggests that limited numbers of epidermal T cells are 
sufficient to induce a tissue-wide state of alert during pathogen 
reemergence. Thus, in addition to the reported increasing efficacy 
of TRM seeding at distal (noninflamed) skin sites after multiple 
infections (Davies et al., 2017), the degree of TRM protection 
at distal sites may represent a graded response depending on 
the degree of general inflammation induced during priming. 
According to this model, strong systemic inflammatory signals 
contribute to the generation of an above-threshold protective 
TRM population at remote skin sites, whereas weaker ones do not. 
Finally, our data are consistent with a scenario where epithelial 
BM serves as a physical barrier to contain transmigrated effector 
T cells in NLT niches and allow them to become TRM through 
changes in expression of transcription factors, chemoattractant 
receptors, and integrins (Mueller et al., 2013; Schenkel and 
Masopust, 2014; Mackay and Kallies, 2017).
In sum, our data define a role for coordinated actomyosin 
activity to allow effector CD8+ T cells to cross ECM barriers in 
NLTs, leading to establishment of protective populations. Regu-
lation of the actin cytoskeleton is emerging as a critical factor for 
fine-tuning of tissue-specific adaptive immune responses.
Materials and methods
Mice
Myo9btm1.2Bah “Myo9b−/−“ mice (Hanley et al., 2010) were back-
crossed to OT-I TCR transgenic mice (Hogquist et al., 1994) and 
Tg(UBC-GFP)30Scha “Ubi-GFP” mice (Schaefer et al., 2001). OT-I 
mice were backcrossed to hCD2-dsRed (Kirby et al., 2009) or Ubi-
GFP mice. Prf1-deficient and CD45.1 mice were provided by the 
Institut für Labortierkunde, University of Zürich, Zurich, Swit-
zerland. C57BL/6 mice were purchased from Janvier (AD Horst). 
All mice were maintained in SPF conditions at the Department of 
Clinical Research animal facility of the University of Bern, Bern, 
Switzerland or at the Theodor Kocher Institute, Bern, Switzer-
land. All animal work has been approved by the Cantonal Com-
mittee for Animal Experimentation and conducted according to 
federal guidelines.
Reagents
Y27632, Rhosin (G04; Shang et al., 2012) and the MLCK inhibitor 
peptide 18 (MLCK inh) were purchased from CalBioChem. The 
LIMK inhibitor S3 was from Anaspec. CCL21, CCL19, and CXCL12 
were provided by PeproTech, and CXCL13 was from R&D Systems. 
CFSE, 5-chloromethyfluorescein diacetate (CMF DA; CellTracker 
green), 7-amino-4-chloromethylcoumarin (CMAC; CellTracker 
blue), and (5-(and-6)-(((4-chloromethyl)benzoyl)amino) tetra-
methylrhodamine; CMT MR; CellTracker orange) were purchased 
from Molecular Probes. Anti-PNAd mAb (MECA-79) was 
affinity purified from hybridoma supernatant (Nanotools) and 
fluorescently conjugated using Alexa Fluor protein–labeling kits 
(Molecular Probes and Invitrogen). For intracellular staining for 
active RhoA, Fc receptors were blocked with purified anti-CD16/
CD32 mAb (2.4G2) in FACS buffer (PBS with 1% FCS and 0.05% 
NaN3) for 10 min. Cells were fixed, permeabilized with Cytofix/
CytoPerm (Becton Dickinson) for 20 min at 4°C, and stained 
with anti-active RhoA mAb from NewEast Biosciences in 
Permwash for 30 min.
Lymphocyte purification
PLN and spleens from wild type and 4- to 8-wk-old Myo9b−/− 
mice were harvested and homogenized using a 70-µm cell 
strainer. Total or CD8+ T cells and B cells were isolated using 
EasySep Negative Selection kits, as described in the manufactur-
er’s instructions (STE MCE LL Technologies). Cell purities were 
typically >95%.
AFM
Cell stiffness was measured using a CellHesion 200 from 
JPK mounted on an inverted Nikon Ti microscopy. Novascan 
cantilevers with a 5-µm borosilicate bead attached and a nominal 
spring constant of 10 pN/nm were used in all experiments. The 
actual spring constant of each cantilever was determined by 
thermal calibration in air. Cantilevers were coated with FBS for 
≥1 h, followed by a coating with 1% Pluronic (P2443, Sigma) to 
avoid adhesion to the cells. Measurements were done in fluid. 
Approach velocity was optimized as 0.5 µm/s to ensure the fastest 
rate of elastic measurement without viscoelastic deformation. 
Retraction speed, which does not affect elasticity measurements, 
was set to 20 µm/s. Cells were plated on a Poly-l-Lysine-coated 
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dish for an hour at 37°C for attachment and thoroughly washed 
before measurements. The cantilever was positioned at the 
desired position by bright field microscopy. Each measurement 
was taken 4–5 times without moving the cantilever in xy and 
averaged. Young’s Modulus of elasticity was calculated by fitting 
the cantilever deflection versus piezo extension curves to the 
modified Hertz model as described (Rosenbluth et al., 2006), 
using the JPK Data Processing software.
Lymphocyte polarization assay
5 × 105 WT and Myo9b−/− purified T cells were plated on top of 
Fibronectin (10 µg/ml, 200 µl, 3 h at 37°C)-coated coverslips. Cells 
were stimulated with 100 nM CCL21 and incubated 1 h at 37°C. T 
cells were fixed with 4% paraformaldehyde (PFA) for 20 min at 
room temperature, permeabilized in Cytofix/CytoPerm (Becton 
Dickinson) for 20 min, blocked in Perm Wash/1% BSA for 5 min 
and labeled with FITC-Phalloidin (Molecular Probes) and DAPI (1 
µg per sample, 1 h room temperature in the dark). In some cases, 
immunostaining was performed with biotinylated anti-CD44 
mAb (BioLegend) or PKCζ mAb (Santa Cruz Technology), fol-
lowed by labeling with Alexa Fluor 488–conjugated streptavidin 
or Alexa Fluor 555–conjugated anti–rabbit pAb, respectively 
(Invitrogen). Fluorescence and phase-contrast images were 
taken with a Zeiss AxioObserver microscope equipped with an 
Apotome, using a 40× objective. T cell length and width were 
measured using Zeiss imaging software and expressed as polarity 
index (i.e., ratio of length to width of the cell).
TCR- and chemokine- induced actin rearrangements
105 total lymphocytes from WT or Myo9b−/− mice were plated 
onto cover glasses in 200 µl medium. To analyze TCR- induced 
actin rearrangements cover glasses were coated with anti CD3ε 
antibody (1 µg per sample, 3 h at 37°C) before plating of 105 WT 
or Myo9b−/− lymphocytes. Cells were fixed with 4% PFA at 2, 5, 
or 10 min after plating. For chemokine-induced actin ruffle for-
mation, cover glasses were coated with Poly-l-Lysine (Sigma). 
After plating of 105 WT or Myo9b−/− lymphocytes, cells were 
stimulated with 100 nM CCL21 for 20 min, followed by fixation 
in 4% PFA for 20 min. Cells were washed with PBS, permeabilized 
with 0.1% Triton/PBS (5 min at room temperature) and labeled 
with FITC-Phalloidin and DAPI. Cover glasses were washed and 
mounted with FluorSave (Calbiochem). Cells were scanned by 
confocal microscopy (Zeiss LSM 510 Meta) and percentages of 
cells showing actin rearrangements were manually quantified 
(at least 100 cells per cover glass were counted manually).
Chemotaxis assay
Isolated T or B cells cell from WT or Myo9b−/− mice were added 
to 5 µm-pore size Transwell Chambers (Costar; 5 × 105/well) and 
allowed to migrate toward 100 nM recombinant mouse CCL21, 
CXL12, CCL19, or CXCL13 for 1 h at 37°C. Chemotaxis efficiency 
and relative input were enumerated by flow cytometry. In some 
experiments, Transwell filters were coated with 5 × 104 Vero 
or Caco-2 cells for 48  h before lysis in distilled water for 30 
min. Filters were coated with Laminin (Sigma; 0.5 µg/50 µl in 
DPBS) for 30 min at 4°C, followed by air drying for 2 h, or with 
30  µl collagen gels polymerized at 37°C prepared as follows: 
low-density collagen (1.6 mg/ml) was prepared by mixing 750 µl 
bovine collagen I (PureCol; Nutacon) with bicarbonate-buffered 
MEM (50 µl 7.5% NaHCO3 and 100 µl 10× MEM; Gibco); high-
density collagen (4.6 mg/ml) was prepared as described above 
using highly concentrated rat collagen I (Becton Dickinson). In 
some experiments, T cells were pretreated with Y27632 (20 µM), 
LIMK inhibitor S3 (10 mg/ml), MLCK inh (20  µM), or Rhosin 
(G04: 0.1–30 µM) for 1 h at 37°C, with inhibitors present during 
chemotaxis assays.
Shear resistant adhesion and in vitro crawling speed
In vitro live cell imaging under flow conditions and coating with 
recombinant mouse ICAM-1 (mICAM-1) was as described (Steiner 
et al., 2010). Before the experiments mICAM-1 was overlaid with 
CCL21. Naive T cells from WT or Myo9b−/− mice were labeled with 
CMAC and CMT MR, respectively, adjusted to 107 cells/ml each, 
mixed in a 1-to-1 ratio and perfused over mICAM at low shear 
stress (0.1 dyn/cm2) for 3 to 4 min. Then, shear was increased to 
physiological strength at 1.5 dyn/cm2 and maintained for 10 to 15 
min. The complete experiment was recorded under 10× objective 
magnification (EC Plan; NA 0.4) with time lapse image acquisi-
tion using a monochrome charge-coupled device camera (Axio-
Cam MRm Rev; Carl Zeiss) at 1 frame each 6 s. For evaluation of 
shear resistant sustained adhesion, we counted T cells/FOV at 20 
to 30 s (accumulated T cells) and at 10 min (sustained adherent 
T cells) after onset of physiological flow and expressed numbers 
in percent of accumulated T cells (=100%). For crawling speed 
under physiological flow, time-lapse videos were analyzed using 
the Manual Tracking Plugin interfaced with Image J software 
(National Institutes of Health). Fluorescent live-cell images were 
acquired with an LCI Plan Neofluar 63×/NA 1.3 glycerol immer-
sion objective and appropriate filters for CMT MR and CMAC.
Collagen motility assays
The assay was performed as previously described (Stolp et al., 
2012). In brief, 3 × 106 splenocytes were stimulated o.n. with IL-2 
(50 U/ml) and ConA (2 µg/ml), followed by WT and Myo9b−/− T cell 
isolation (EasySep Mouse T cell Negative Selection kit; STE MCE 
LL Technologies). WT or Myo9b−/− T cells (3 × 105 in 50 µl 0.5% 
FCS-reduced media) were mixed with 100 µl low-density collagen 
matrix (1.6 mg/ml) and allowed to polymerize at 37°C within self-
constructed migration chambers. Gels were spiked with CCL21 100 
nM (PeproTech) and sealed with melted dental wax. Micrographs 
were acquired every 60 s for 120 min at 37°C using a 10× objective 
(EC Plan; NA 0.4) with bright field on an inverse light microscope 
(10× objective, Axiovert 200M; Zeiss) coupled to an electron 
microscopic charge-coupled device camera (Roper Scientific). 
Migrating cells were tracked manually using the Fiji manual 
tracking plugin and analyzed with the chemotaxis tool plugin. 
We used 5 µm/min as threshold for arrest coefficient analysis.
Under agarose assay
Under agarose assays were essentially performed as described 
(Renkawitz et al., 2009). In brief, WT or Myo9b−/− T cell blasts 
were injected between a glass coverslip and an agarose layer. 
Migrating cells were tracked manually using the Fiji manual 
tracking plugin and analyzed with the chemotaxis tool plugin.
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Homing and 3D immunofluorescence
CFSE- and CMT MR-labeled WT and Myo9b−/− T cells (107/mouse) 
were coinjected i.v. into sex-matched 5- to 10-wk-old C57BL/6 
recipient mice. At 2 h after adoptive transfer, blood was collected 
from the submandibular plexus, mice were killed using CO2, 
and perfused with 5 ml cold PBS. PLN, MLN, and spleens were 
homogenized using a 70-µm cell strainer. Cell suspension was 
analyzed using a FACS Calibur (BD) and FlowJo software (Tree 
Star). For three-dimensional immunofluorescence (3-DIF; 
Boscacci et al., 2010), 3 × 106 CMAC- and CMT MR-labeled WT and 
Myo9b−/− purified T cells were coinjected i.v. into sex-matched 5- to 
10-wk-old C57BL/6 recipient mice. 20 min after adoptive transfer, 
100 µg Mel-14 mAb (anti–L-selectin) and 5 µg Alexa Fluor 633–
conjugated MECA-79 mAb (anti-PNAd) were injected i.v.; 20 min 
later, mice were killed using CO2, perfused with 5 ml cold PBS, and 
fixed in 10 ml cold 1% PFA/PBS. PLNs were collected and manually 
cleaned from surrounding fat tissue under a stereomicroscope. 
After o/n fixation in PBS/1% PFA, PLNs were embedded into 
2% (wt/vol) agarose low gelling point (Sigma), dehydrated in 
methanol for 24 h, and cleared for at least 2 d in benzyl alcohol/
benzyl benzoate (1:2 ratio). Blocks of agarose-embedded PLNs 
were imaged using a 2PM setup (TrimScope; LaVision Biotec). 
The absolute number of lymphocytes labeled with each dye was 
counted using Volocity software (PerkinElmer). Visual analysis 
of individual z-sections was used to determine the position of 
individual cells relative to the HEV network.
Extrapolating T cell tracks in lymph nodes and 
skin for simulation
To extrapolate short 2PM T cell tracks from the LN to “12 h” in sil-
ico tracks, we drew a random sample of their step sizes, turning 
angles, and plane angles, i.e., the angle between the planes of two 
consecutive turns. To account for autocorrelation, we calculated 
the means of the squared differences between consecutive step 
sizes and turning angles, neglecting the small autocorrelation 
in the plane angles. We then randomly exchanged steps if both 
these means of the synthetic tracks came closer to the means of 
the 2PM tracks. We stopped once both simulated means were 
smaller than the measured means. To simulate contact forma-
tion, we normally distributed 100 of these tracks with a stan-
dard deviation of 150 µm, such that half of the tracks stayed for 
11 h within the spherical T cell zone of 1-mm diameter. We then 
uniformly distributed 50 or 104 static DCs within the T cell zone 
and assumed T cells closer than 15 µm to form stable contacts. 
We repeated these simulations 50 times in each configuration 
to get stable distributions of the numbers of T cells in contact. 
Analogously, we extrapolated tracks from the skin to 24 h tracks 
in two dimensions by sampling and reshuffling step sizes and 
turning angles in the xy plane. The simulations were performed 
using Python and open source libraries for scientific computing 
(McKinney, 2010; Pedregosa et al., 2012; Waskom et al., 2014).
DC culture and peptide pulsing
Bone marrow cell suspensions from GFP-expressing mice were 
obtained by centrifugation (4,000 rpm; 4 min) of femurs and 
tibiae and incubated in 20-ml cultures containing 18 ml CM-R 
and 2 ml SP-20 supernatant containing Flt3L for 6 to 9 d. Cells 
were stimulated with LPS (1 µg/ml; Sigma-Aldrich) for 24 h and 
pulsed with indicated concentrations of OVA257–264 peptide (SII 
NFE KEL; ECM Microtechnologies) for 45 min at 37°C.
2PM of popliteal LN
CMAC- or CMT MR-labeled WT or Myo9b−/− polyclonal or OT-I 
CD8+ T cells (3 × 106) were adoptively transferred into C57BL/6 
recipient mice. In some experiments, GFP+ DCs (2 × 106/mouse) 
were pulsed with 100 or 1000 nM OVA257–264 peptide and s.c. injected 
into hind footpad of 5- to 10-wk-old sex-matched C57BL/6 mice 
18 h before adoptive transfer. Immediately after injection, 2PM 
imaging (TrimScope) was performed with an Olympus BX50WI 
fluorescence microscope and a 20× objective (NA 0.95). For four-
dimensional analysis of cell migration, 10–16 z-stacks (spacing 4 
µm) of 200- to 300-µm2 xy-sections were acquired every 6 to 20 s 
for 10 to 30 min. Imaging was performed in the T cell area identified 
by the presence of HEVs labeled using Alexa Fluor 633-conjugated 
MECA-79. Sequences of image stacks were transformed into 
volume-rendered four-dimensional videos using Volocity software 
(PerkinElmer), which was also used for semiautomated tracking 
of cell motility in three dimensions. The mean track velocity and 
turning angles (defined as the angle between the two velocity 
vectors before and after a measurement time point) were calculated 
from the x, y, and z coordinates of cell centroids (Mempel et al., 
2004). The cutoff for arrest coefficient calculation was set to 4 
µm/min. To calculate two-dimensional “circularity,” LN Videos 
of four-dimensional volume-rendered datasets were generated 
using Volocity software and converted to image sequences with 
QuickTime Pro. Individual cell tracks of the image sequence were 
compared with their original four-dimensional–rendered image 
sequence to identify all time frames when cells were with the entire 
circumference inside the imaging volume, with time points where 
cells were only partially in the imaging volume being manually 
discarded using Adobe Photoshop. The shape factor of filtered 
image sequences was reanalyzed using Volocity software to yield 
circularity. To calculate three-dimensional “sphericity,” the shape 
factor of volume-rendered four-dimensional image sequences 
from skin videos was measured using Volocity software without 
any modification, because single cells remained present in the 
epidermis throughout the duration of the recording.
In vivo proliferation and flow cytometry for activation markers
DsRed+ WT and GFP+ OT-I Myo9b−/− CD8+ T cells were labeled 
with e670 (5 µM, 20 min) and analyzed for cell division and 
activation markers expression 24, 48, or 72 h after transfer into 
mice with pMHC-bearing DCs as described for 2PM experiments. 
Cell surface stainings were performed with the appropriate 
combinations of saturating concentrations of the following 
conjugated mAbs obtained from BioLegend: CD25 (3C7), CD69 
(H1.2F3), CD103 (2E7), CXCR3 (CXCR3-173), CD127 (A019D5), 
KLRG1 (14C2A07), and CD8 (53–6.7). Flow cytometry was 
performed on a LSR II (Becton Dickinson) and FlowJo software 
(Tree Star) was used for analysis.
Viral infections
Ovalbumin-expressing rLCMV-OVA was generated according to 
established procedures (Emonet et al., 2009; Flatz et al., 2010). 
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WT or Myo9b−/− CD8+ T cells (104/mouse) were injected i.v. into 
different sex-matched 5- to 10-wk-old Ubi-GFP recipient mice. 
24 h later, mice were i.p. infected with 105 plaque-forming units 
(pfu) of LCMV-OVA. Mice were bled or killed at indicated days 
after infection for flow cytometry analysis. For HSV-1TOM-OVA 
infections, GFP+ OT-I WT or Myo9b−/− CD8+ TCM (5 × 105/mouse) 
isolated from spleens and LNs of LCMV-OVA–immunized mice 
at day 30 after infection were adoptively transferred into recip-
ient mice. 1 d later, intraepithelial infection was performed on 
the shaved flank of anesthetized mice by tattooing a 10-µl drop-
let containing 5 × 105 pfu HSV-1TOM-OVA encoding tandem dimer 
tomato and ovalbumin onto the skin using a sterile disposable 
9-needle bar mounted on a rotary tattoo device as described 
(Ariotti et al., 2015). Vero cells, seeded in 6-well plates at a den-
sity of 4 × 10 5 cells per well such that monolayers were confluent 
the following day, were infected with serial dilutions of homog-
enized skin biopsies (10-mm diameter; MagNA Lyser, Roche) for 
45 min. After incubation in medium containing 0.5% methyl-
cellulose for 72 h, plaques were identified by 0.1% crystal violet 
staining and counted. To assess TRM function, 3 × 105 dsRed+ WT 
or GFP+ Myo9b−/− OT-I T cells were injected i.v. into sex-matched 
Prf1−/− recipients. 1 d later, recipient mice were infected i.p. with 
105 pfu LCMV-OVA. On day 3 after infection, mice were anesthe-
tized with ketamine/xylazine. One flank was shaved and resid-
ual hair removed with depilating cream before OVA257–263 peptide 
(2.5 ng in 10 µl PBS/10% DMSO) was tattooed onto the shaved 
flank. During day 29 and 32 after infection, mice were treated 
daily with an i.p. injection of FTY720 (1 mg/kg in 0.9% NaCl; 
Sigma) to prevent recruitment of circulating cells to the skin 
during rechallenge. On day 30, HSV-1TOM-OVA was tattooed into 
the skin of both flanks and viral titers determined as above. As 
controls, we infected untreated Prf1−/− mice that had not received 
OT-I T cells to determine “no cells” viral titers.
Quantification of skin sections by immunohistology
Formalin-fixed paraffin-embedded consecutive sections (4 µm) 
were dewaxed and dehydrated by a graded decrease alcohol series 
and stained for histology or immunohistochemical characterization 
(IHC). For histological analysis in bright-field microscopy, slides 
were stained using standard protocols for H&E (using Mayer’s H&E; 
BioOptica) and Sirius red staining (Direct Red 80, Sigma) for colla-
gen fibers. For IHC, slides were immunostained for anti-GFP mAb 
(Thermo Fisher Scientific) and anti-RFP mAb (Rockland) according 
to the manufacturers’ instructions. Control experiments showed 
that on day 8 after infection, no tdTomato-expressing HSV-1TOM-
OVA–infected cells were detectable in skin. After antigen unmasking 
with citrate buffer, pH 6.0, endogenous peroxidase activity was 
inhibited by incubating slides with 3% peroxidase water for 20 min 
at RT. Both mAbs were used at dilution of 1:200 and developed with 
EXP OSE rabbit-specific HRP/DAB detection IHC kit (ab80437). After 
immunostaining, DAB substrate chromogen was applied to sections 
for 5 min at RT and counterstained with Mayer’s Hematoxylin, dehy-
drated, and mounted with Eukitt (BioOptica). Proper external pos-
itive and negative controls were run simultaneously. Slides were 
acquired with Aperio AT2 digital scanner at magnification of 200× 
(Leica Biosystems). Cells in epidermis and papillary dermis were 
counted manually.
2PM of skin
For skin intravital microscopy (IVM), the right flank of anes-
thetized mice was shaved and depilated using Veet (Reckitt 
Benckiser). Parallel incisions were made 15 mm apart in the 
skin flank before separating from the underlying peritoneum. A 
stable imaging platform was established by inserting an 18-mm 
stainless steel disk under the dermis. The underside of the der-
mis was glued to the steel disk using Vetbond tissue adhesive 
(3M). Images were acquired and analyzed as described above. 
For four-dimensional analysis of cell migration, 13–25 z-stacks 
(spacing 2.5 µm) of 250–450 µm2 xy sections were acquired every 
60 s for 1 to 2 h. Imaging was performed in the epidermis and 
in the dermis was identified by the presence of dermal collagen 
fibers identified by second harmonic green (SHG) signal. We 
also used SHG signal as anatomical reference channel for real-
time offset correction to minimize tissue shift (Vladymyrov et 
al., 2016). In this system, SHG signal shifts between frames are 
detected through fast computational analysis for feedback to an 
automated stage that performs a corrective motion before the 
next stack is acquired. In some experiments, OVA257–264 peptide 
(2.5 ng of peptide in PBS/10% DMSO) was tattooed in the flank of 
anesthetized mice before 2PM surgical preparation. Images were 
acquired from 1 to 8 h after OVA257–264 delivery. Membrane pro-
trusion analysis was performed on epidermal 2PM videos, using 
the ADA PT plugin for ImageJ (Barry et al., 2015). The mean pro-
trusion speed per cell was calculated for a membrane protrusion 
size range of 0.2–5 µm2.
Scanning electron microscopy
ECM-coated filters were produced as described in chemotaxis 
assays. 5 × 104 Vero or CaCo-2 cells were seeded on top of 5 µm 
pore Transwell filters and incubated for 2 d at 37°C. Filters were 
fixed with 4% PFA (Merck) and 0.1% glutaraldehyde (Merck) 
in PBS for 1 h at room temperature. Samples were dehydrated 
through an ascending ethanol series and dried by evaporation of 
hexamethyldisilazane (Merck) as described previously (Stoffel 
and Friess, 2002). Samples were mounted on metal stubs with 
conductive adhesive pads (Ted Pella) and sputter-coated with ∼20 
nm of gold with an SCD004 Sputter Coater (BalTec). Secondary 
electron micrographs were obtained with a field emission 
scanning electron microscope DSM 982 Gemini (Zeiss) at an 
accelerating voltage of 5 kV at a working distance of 6–8 mm.
Analysis of in vitro cytotoxicity
DsRed+ WT or GFP Myo9b−/− cells OT-I TCM cells were isolated 
from skin of HSV-1TOM-OVA-infected mice on day 30 after infection 
using BD FAC SAria cell sorter. 104 sorted WT or Myo9b−/− cells 
were mixed with 5 × 104 purified unpulsed B cells labeled with 
0.5  µM e670 or 5 × 104 OVA257–264–pulsed B cells labeled with 
10  µM e670 (20 min, 37°C). After 24  h at 37°C, 5% CO2, cell 
suspensions were analyzed for the ratio of e670high to e670low B 
cells using a FACS Calibur (Becton Dickinson).
Statistical analysis
Data were analyzed using Prism 6 (GraphPad) using Student’s t 
test, ANO VA, and nonparametric tests as indicated in the Figure 
legends. P-values <0.05 were considered significant.
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Online supplemental material
Fig. S1 depicts the comparable phenotype of naive WT and Myo9b−/− 
T cells. Fig. S2 describes lymphocyte compartments of WT and 
Myo9b−/− mice with decreased cellularity in the latter. Fig. S3 
shows comparable in vitro activation of WT and Myo9b−/− T cells. 
Fig. S4 depicts the localization of WT and Myo9b−/− OT-I T cells 
on day 8 after infection with HSV-1TOM-OVA, with fewer epidermal 
Myo9b−/− T cells. Fig. S5 shows the low Transwell migration of 
Myo9b−/− T cells across the ECM layer of lysed epithelial cell lines. 
Videos 1 and 2 show largely comparable motility of naive WT and 
Myo9b−/− T cells in lymphoid tissue (Video  2 is high temporal 
resolution mode). Video 3 depicts comparable interactions of WT 
and Myo9b−/− OT-I T cells with peptide-loaded DCs. Videos 4 and 
5 show WT and Myo9b−/− OT-I T cells in epidermis. Video 6 shows 
WT and Myo9b−/− OT-I T cells in dermis. Video 7 depicts migration 
of a dermal Myo9b−/− OT-I T cell close to the epidermal layer.
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